Regarding tumor characteristics, PD-L1 expression in metastatic tumors was associated with higher differentiation (p = 0.020) and fewer lymph node metastasis (PD-L1- vs PD-L1+: 67.6% vs 41.2%, p = 0.025). Here, CD274 is linked to metastatic neoplasm.